Results (4282)


Overall survival and incidence of adverse events in B-cell acute lymphoblastic leukemia (ALL) patients after allogeneic stem cell transplant: blinatumomab vs non-blinatumomab chemotherapy-- an analysis of the Center for International Blood and Marrow Transplant Research database (20170610) (Transplant outcomes among ALL in CIBMTR)
Austria
Belgium
Bulgaria
Canada
Croatia
Cyprus
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
United States
EU PAS number:
EUPAS33745
First published:
12/05/2025
StudyFinalised
Tafamidis Pregnancy Surveillance Study
Canada
France
Germany
Japan
Portugal
Spain
United Kingdom
United States
EU PAS number:
EUPAS37119
First published:
12/05/2025
StudyOngoing
InGef Research Database
First published:
07/05/2025
Germany
Data source
Human
Administrative healthcare records (e.g., claims)